Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Amino Terminal Sequence
100%
DNA B
100%
Lipopolysaccharide
100%
Phosphotransferase
100%
DNA Binding
100%
Nuclear Factor
100%
Binding Affinity
100%
Skeletal Muscle
100%
Patient with Type 2 Diabetes
75%
Glucose Tolerance
75%
Muscle Biopsy
50%
Messenger RNA
50%
Glucose Uptake
50%
Western Blot
25%
Acetyl-CoA
25%
Informed Consent
25%
Hyperglycemia
25%
Carboxylase
25%
Physical Examination
25%
Cytokine
25%
Interleukin 6
25%
Diabetes
25%
Escherichia coli
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Biopsy Sample
25%
Enzyme Linked Immunosorbent Assay
25%
Glucose Metabolism
25%
Volunteer
25%
Tumor Necrosis Factor
25%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
DNA Binding
100%
Skeletal muscle
100%
Nuclear factor-B
100%
AMP-activated Protein Kinase Phosphorylation
100%
Lipopolysaccharide
100%
Kinase Phosphorylation
100%
C-Jun N-terminal Kinase
100%
Normal Glucose Tolerance
75%
Systemic Inflammation
75%
Type 2 Diabetic Patients
75%
Glucose Uptake
50%
Glucose Disposal
25%
Tumor Necrosis Factor-α
25%
Diabetes
25%
Quantitative PCR
25%
Intravenous Bolus
25%
Inflammatory Pathways
25%
Interleukin-6
25%
Trial Registration
25%
Ethical Approval
25%
Informed Consent
25%
Skeletal muscle Biopsy
25%
Western Blotting
25%
Acetyl-CoA Carboxylase
25%
Impaired Glucose Metabolism
25%
Hyperglycemia
25%
Between-group
25%
AMP-activated Protein Kinase
25%
Muscle Biopsy
25%
MRNA Expression
25%
Dysregulated
25%
Cytokine mRNA Expression
25%
Escherichia Coli Lipopolysaccharide
25%
Binding Activity
25%
Inflammation
25%
Biopsy Specimen
25%
Neuroscience
Alternative Complement Pathway C3 C5 Convertase
100%
Binding Affinity
100%
DNA B
100%
Kinase
100%
AMP-activated Protein Kinase
100%
DNA Binding
100%
Amino Terminal Sequence
100%
Nuclear Factor
100%
Lipopolysaccharide
100%
Skeletal Muscle
100%
Glucose Transport
50%
Messenger RNA
50%
Necrosis
25%
ELISA
25%
Physical Examination
25%
In Vivo
25%
Blood Plasma
25%
Metabolic Pathway
25%
Interleukin 6
25%
Acetyl-CoA
25%
Reverse Transcription Polymerase Chain Reaction
25%
Blood Clotting Factor 6
25%
Carboxylase
25%
Western Blot
25%
Hyperglycemia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Lipopolysaccharide
100%
Phosphotransferase
100%
Non Insulin Dependent Diabetes Mellitus
100%
Nuclear Factor
100%
Messenger RNA
50%
Carboxylase
25%
Acetyl-CoA
25%
Tumor Necrosis Factor
25%
Interleukin 6
25%
Enzyme-Linked Immunosorbent Assay
25%
Western Blot
25%
Hyperglycemia
25%
Escherichia coli
25%
Cytokine
25%
Immunology and Microbiology
Complement Factor B
100%
Binding Affinity
100%
DNA Binding
100%
Amino Terminal Sequence
100%
Skeletal Muscle
100%
Systemic Inflammation
75%
Glucose Transport
50%
Muscle
25%
Escherichia coli
25%
Interleukin 6
25%
Glucose Metabolism
25%
Cytokine
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Blood Plasma
25%
Tumor Necrosis Factor
25%
ELISA
25%
Western Blot
25%